EINDHOVEN, Netherlands, Nov. 30, 2015 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ:NXPI) will host a media and industry analyst conference call after regulatory approvals and announcement of close of the merge with Freescale Semiconductor. The conference call will take place on Monday, December 7, 2015 at 11:00 AM U.S. Eastern Daylight Time.
WHAT: Conference call and webcast to share information following close of NXP and Freescale Semiconductor merger.
WHO: SPEAKERS
Steve Owen, Executive Vice President, Sales and Marketing, NXP
Kurt Sievers, Executive Vice President and General Manager of the Automotive Business, NXP
Ruediger Stroh, Executive Vice President and General Manager Security and Connectivity, NXP
WHEN: Monday, December 7, 2015 at 11:00 a.m. U.S. Eastern Daylight Time.
CONFERENCE DIAL IN:
Within the U.S.: 1 - 888 - 311 - 8119
Outside the U.S.: 1 - 330 - 863 - 3362
Participant Pass-code: 87721254
WEBCAST LINK: http://edge.media-server.com/m/p/f32vsyz4/lan/en
REPLAY: The call will be webcast by NASDAQ OMX. Audio archive replay will be available for 90 days following the call and can be available upon request.
About NXP Semiconductors
NXP Semiconductors N.V. (NASDAQ:NXPI) creates solutions that enable secure connections for a smarter world. Building on its expertise in high-performance mixed signal electronics, NXP is driving innovation in the areas of connected car, security, portable & wearable, and the Internet of Things. NXP has operations in more than 25 countries, and posted revenue of $5.65 billion in 2014. Find out more at www.nxp.com.
Forward-looking Statements
This document includes forward-looking statements which include statements regarding NXP’s business strategy, financial condition, results of operations, and market data, as well as any other statements which are not historical facts. By their nature, forward-looking statements are subject to numerous factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those projected. Readers are cautioned not to place undue reliance on these forward-looking statements. Except for any ongoing obligation to disclose material information as required by the United States federal securities laws, NXP does not have any intention or obligation to publicly update or revise any forward-looking statements after NXP distributes this document, whether to reflect any future events or circumstances or otherwise. For a discussion of potential risks and uncertainties, please refer to the risk factors listed in NXP’s SEC filings. Copies of NXP’s SEC filings are available on NXP’s Investor Relations website, www.nxp.com/investor or from the SEC website, www.sec.gov.
For further information, please contact: Tate Tran [email protected] +1 408 802 0602 Jack Taylor [email protected] +1 512 560 7143


Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Shell M&A Chief Exits After BP Takeover Proposal Rejected
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



